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Comprehensive mapping of O-GlcNAc
modification sites using a chemically
cleavable tag†
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The post-translational modification of serine or threonine residues
of proteins with a single N-acetylglucosamine monosaccharide
(O-GlcNAcylation) is essential for cell survival and function. However,
relatively few O-GlcNAc modification sites have been mapped due to
the diﬃculty of enriching and detecting O-GlcNAcylated peptides
from complex samples. Here we describe an improved approach to
quantitatively label and enrich O-GlcNAcylated proteins for site
identification. Chemoenzymatic labelling followed by copper(I)-
catalysed azide–alkyne cycloaddition (CuAAC) installs a new mass
spectrometry (MS)-compatible linker designed for facile purification
of O-GlcNAcylated proteins from cell lysates. The linker also allows
subsequent quantitative release of O-GlcNAcylated proteins for
downstream MS analysis. We validate the approach by unambiguously
identifying several establishedO-GlcNAc sites on the proteins a-crystallin
and O-GlcNAc transferase (OGT), as well as discovering new, previously
unreported sites on OGT. Notably, these novel sites on OGT lie in
key functional domains of the protein, underscoring how this site
identification method may reveal important biological insights into
protein activity and regulation.
The dynamic and reversible post-translational modification of intra-
cellular proteins by b-linked O-GlcNAc, known as O-GlcNAcylation,
is necessary for the regulation of numerous cellular processes,
including transcription, translation, protein homeostasis, and meta-
bolism.1–6 Alterations in O-GlcNAcylation are associated with human
diseases such as cancer, diabetes, and neurodegeneration.6–8 How-
ever, understanding the roles of O-GlcNAcylation in specific physio-
logical contexts will require a more comprehensive characterization
of the O-GlcNAc proteome and the modification sites on proteins.
Notably, although thousands of proteins have been putatively shown
to be O-GlcNAcylated,9–15 relatively few glycosylation sites have been
mapped. Mass spectrometric (MS) identification of O-GlcNAcylated
peptides from complex mixtures has been challenging due to the
substoichiometric nature of O-GlcNAcylation and is further
exacerbated by suppression of O-GlcNAc peptide ionization in
the presence of the unmodified peptide.16 Thus, improved
methods to enrich O-GlcNAcylated peptides or proteins are
much needed, particularly approaches that can be directly used
in conjunction with MS/MS sequencing to achieve a more
comprehensive understanding of O-GlcNAc modification sites.
Robust enrichment of O-GlcNAcylated proteins can be accom-
plished using a two-step chemoenzymatic approach.11,17 First, the
O-GlcNAc moiety is tagged with a non-natural azide group by
treatment of cell lysates with UDP-GalNAz 1 and a mutant galacto-
syltransferase (Y289L GalT)18 that specifically recognizes terminal
GlcNAc moieties (Fig. 1). Next, a biotin group is attached via
copper(I)-catalysed azide–alkyne cycloaddition (CuAAC),19 which
allows for affinity purification. Although a limited set of alkyne-
biotin linkers are commercially available, many existing linkers are
not ideal for mapping O-GlcNAc modification sites. In particular,
harsh conditions are usually required to disrupt the femtomolar
biotin–streptavidin interaction,20 which may hydrolyse the labile
O-GlcNAc moiety. Additionally, many linkers contain a large
spacer between the biotin group and the alkyne functionality,
which appends a relatively large mass to the glycopeptide and
can preclude its sequencing by mass spectrometry.20 Therefore, a
facile method to release the labelled peptides and proteins with
minimal added mass would greatly facilitate downstream analysis.
Several cleavable linkers have been previously developed for
the enrichment of O-GlcNAcylated proteins.13,15,16,21 However,
each suﬀers from significant drawbacks for site identification. For
example, a photocleavable linker was employed in conjunction
with UDP-GalNAz 1 and Y289L GalT to sequence modified peptides
from mouse brain lysate.15,16 Importantly, the moiety retained after
cleavage provided a positively-charged amine group, which increased
the overall peptide charge and facilitated ionization by electron-
transfer dissociation (ETD), the most successful MS/MS method
for O-GlcNAc peptide sequencing.12,22 Unfortunately, cleavage
of the linker was found to be incomplete.16 In a recent report, a
dibromine-containing, acid-cleavable linker was employed to
identify various glycan modifications including O-GlcNAc.21
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However, cleavage of the linker revealed only a neutral hydroxyl
group, and the halogenated glycopeptides demonstrated poor
fragmentation eﬃciency using ETD. Therefore, we aimed to
develop a tag that would be quantitatively appended and
released, as well as incorporate a positive charge upon cleavage
to facilitate ETD-MS detection.
To achieve these dual goals, we chose to examine the 1-(4,4-
dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl (Dde) functional group
(Fig. 1A). The Dde moiety has been used extensively as a protecting
group for lysine in peptide synthesis,23 demonstrating its
compatibility with biomolecules. The group is stable to both
acid and base and can be quantitatively removed by hydrazine.24
However, it was reported that the Dde group is incompatible
with sodium dodecyl sulphate (SDS) and amine-containing
buﬀers, common additives to protein labelling protocols.25
We first investigated the labelling of a model O-GlcNAcylated
peptide with commercially available alkyne-Dde-biotin 2 followed by
cleavage of the linker using liquid chromatography (LC)-MS (Fig. 1B
and 2). Commercially available peptide TAPT(gS)TIAPG (Fig. 2A),
where gS is the O-GlcNAcylated residue, was incubated with
100 ng mL1 of Y289L GalT and 1 mM of UDP-GalNAz 1 in 10 mM
HEPES pH 7.9, 5.5 mM MnCl2 overnight at 4 1C. LC-MS analysis
revealed quantitative conversion to the desired GalNAz-labeled
product (Fig. 2B). Next, the azide-containing peptide was reacted with
100 mM of 2 in 10 mM sodium phosphate pH 7.6 containing 2 mM
sodium ascorbate (NaAsc), 100 mM THPTA, and 1 mM CuSO4. After
1 h, stoichiometric biotinylation of the peptide was observed (Fig. 2C).
Treatment with 2% aqueous hydrazine for 1 h at RT resulted in
quantitative cleavage of the linker to aﬀord a minimal, positively-
charged aminomethyltriazolyl group (Fig. 1B and 2D). To test whether
the linker would be stable under stringent wash conditions, we
incubated the labelled peptide with 1% RapiGest, a MS-compatible
analogue of SDS, or 6 M urea for 1 h at RT (Fig. S1, ESI†). In both
cases, the linker remained intact, highlighting the compatibility of
the linker with rigorous washing steps.
We next tested the performance of our linker in comparison to a
previously described, widely utilized photocleavable linker
(alkyne-PC-biotin).16 Briefly, HEK-293T cell lysate was subjected
to chemoenzymatic labelling with 1 using Y289L GalT as
described above. The azide-labelled protein was then split into
two equal fractions and reacted with either 2 or alkyne-PC-biotin
Fig. 1 (A) Chemicals used in the labelling protocol. (B) Schematic of O-GlcNAc
protein enrichment and elution using the two-step chemoenzymatic/CuAAC
labelling protocol.
Fig. 2 Labelling and cleavage reactions proceed quantitatively. Reverse phase LC-MS analysis of O-GlcNAc peptide labelling reactions at (A) time 0, (B) 16 h
after addition of 1 and Y289L GalT, (C) 1 h after CuAACwith 2, and (D) 1 h after cleavage with 2% aqueous hydrazine. See ESI† for experimental details. (A) and
(B) show base peak chromatograms. (C) and (D) show extracted ion chromatograms of the starting material and product within 1m/z of calculated values.
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by CuAAC. An aliquot of each sample was reserved for analysis, and
the remainder of each sample was subjected to cleavage using 2%
hydrazinemonohydrate or by UV irradiation at 365 nm. The samples
were resolved by SDS-PAGE and probed for biotin using streptavidin
conjugated to AlexaFluor 680 dye (Fig. 3). Notably, a stronger biotin
signal was observed for lysate labelled with 2 compared to alkyne-PC-
biotin, suggesting higher labelling eﬃciency with the Dde linker.
Furthermore, although both linkers cleaved well, the photocleavable
linker showed slightly higher residual signal compared to 2,
suggesting that the Dde moiety was also released more eﬃciently
than the photocleavable group. These results demonstrate that
our new approach provides an improvement in both labelling
eﬃciency and recovery of O-GlcNAcylated proteins compared to
the most widely used method.
We then evaluated the potential of the approach to pull
down known O-GlcNAcylated proteins and identify sites of
modification. The well-characterized O-GlcNAcylated protein
a-crystallin was selected to assess the sensitivity of the method
because it has a relatively low glycosylation stoichiometry
(o10%).26 Short-form OGT (sOGT)27,28 from Sf9 cells has multiple
sites of O-GlcNAcylation12 and was thus used to determine whether
comprehensive site mapping could be achieved. To test the robust-
ness of our method in a complex mixture, each protein was
added to 200 mg of adult mouse cortical lysate and subjected to
chemoenzymatic labelling and CuAAC using 2. The labelled
proteins were applied to high-capacity Neutravidin resin and
washed with 1% SDS, 6 M urea, and phosphate buﬀered saline
(PBS). The resin was then incubated for 1 h with 2% aqueous
hydrazine to cleave the O-GlcNAcylated proteins from the resin.
Eluted samples were precipitated, re-dissolved in denaturing
buﬀer, and subjected to reduction, alkylation, and proteolytic
digestion. Digested peptides were separated by nanoLC-MS and
analysed on an LTQ-Velos by a combination of collision-induced
dissociation (CID) and ETD-MS.
Impressively, a large number of O-GlcNAcylation sites were
identified on a-crystallin and sOGT (Table 1). The known O-GlcNAc
site on a-crystallin A (Ser-162)29 was readily recognized despite
the low abundance of the O-GlcNAc modification at this site.
Importantly, we observed both known and novel sites on
sOGT.12,30 For example, we identified the previously reported
Thr-662 site, which is found in the catalytic domain of sOGT.15 The
new linker design also revealed a number of new O-GlcNAcylation
sites within the N-terminal tetratricopeptide repeat-containing
(TPR) domains (Ser-10/Thr-12, Ser-20, Ser-52, and Ser-56) of sOGT,
and we observed a doubly modified peptide at both Ser-10/Thr-12
and Ser-20, highlighting the sensitivity of the approach to identify
novel glycosylation sites and multiply occupied states. As the TPR
domains of OGT are thought to mediate protein–protein inter-
actions,31–33 such modifications could play an integral role in OGT
regulation and may provide a mechanism to selectively modulate
its activity toward specific substrates.
Conclusions
Herein we describe an improved method to facilitate the compre-
hensive mapping of O-GlcNAcmodification sites. Chemoenzymatic
attachment of an azide-containing monosaccharide onto O-GlcNAc
sugars provides a stoichiometric, bioorthogonal handle, which is
further functionalized with an alkyne-Dde-biotin linker to isolate
and enrich O-GlcNAcylated proteins. The cleavable Dde linker
provides numerous benefits over other reported structures. First,
the linker is commercially available and inexpensive. Second, it is
Fig. 3 Alkyne-Dde-biotin linker 2 outperforms a widely used alkyne-
photocleavable-biotin linker (PC). Protein lysates labelled with 2 show
higher biotin signal after labelling (lane 2 vs. lane 4) and lower residual
signal after cleavage (lane 3 vs. lane 5) compared to the PC linker. See
Fig. S2 (ESI†) for full Coomassie gel.
Table 1 O-GlcNAc sites identified following labelling with 2, Neutravidin aﬃnity purification, and hydrazine-mediated elution. Sites and regions of
modification are denoted in red or red underline, respectively. Novel site identifications are marked by an asterisk
Protein Peptide sequence Site(s) Mascot ion score Mascot delta ion score Method
a-Crystallin A Ser-162 24.9 23.5 ETD
sOGT Ser-10*/Thr-12* 46.5 — ETD
sOGT Ser-20* 21.6 13.6 ETD
sOGT Ser-10*/Thr-12*, Ser-20* 38.4 — ETD
sOGT Thr-38 41.8 35.0 CID
sOGT Ser-52* 53.5 7.9 ETD
sOGT Ser-56* 56.8 15.7 ETD
sOGT Thr-662 33.1 8.0 ETD
Molecular BioSystems Communication
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
0 
M
ar
ch
 2
01
6.
 D
ow
nl
oa
de
d 
on
 2
0/
06
/2
01
6 
16
:1
5:
52
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is©The Royal Society of Chemistry 2016 Mol. BioSyst., 2016, 12, 1756--1759 | 1759
stable to rigorous, denaturing wash conditions and can be quantita-
tively cleaved under mild chemical conditions. Finally, the cleaved
moiety that remains on themodified peptideminimally changes the
peptide mass and generates an additional positive charge, which
facilitates peptide sequencing by ETD. Together, in combination
with the commercially available chemoenzymatic labelling kit,11 the
method provides an accessible and practical system for the broader
community. Using this approach, we identified established sites
on both a-crystallin and sOGT and new modification sites on
sOGT, including novel sites for OGT regulation. Our results
showcase the method’s potential to comprehensively profile
protein O-GlcNAcylation. The stoichiometric nature of the
chemoenzymatic labelling, CuAAC reaction, and elution steps
provides an ideal platform for future quantitative MS analyses to
profile global O-GlcNAcylation and will enable the discovery of
novel functional roles for O-GlcNAcylation in diverse biological
settings.
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